x
Breaking News
0

Adamis Pharma (ADMP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Adamis Pharmaceuticals Corporation's earnings

Delivery Method

Status

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.53 -0.17    -3.54%
15:02:47 GMT - Real-time CFD Data. Currency in USD ( Disclaimer )
Type: Equity
Market: United States
ISIN: US00547W2089 
CUSIP: 00547W208
  • Volume: 123,328
  • Bid/Ask: 4.50 / 4.55
  • Day's Range: 4.51 - 4.65
START TRADING NOW
Adamis Pharmaceuticals Corporation 4.53 -0.17 -3.54%

ADMP Overview

 
Information about the Adamis Pharma Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close4.7
Day's Range4.51 - 4.65
Revenue9.52M
Open4.65
52 wk Range2.4 - 6.45
EPS - 0.89
Volume123,328
Market Cap147.35M
Dividend (Yield)0 (N/A)
Average Vol. (3m)1,300,859
P/E RatioN/A
Beta0.06
1-Year Change77.36%
Shares Outstanding31,351,334
Next Earnings DateN/A

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Strong Sell Sell Neutral
Technical Indicators Strong Sell Strong Sell Strong Sell Strong Sell Strong Buy
Summary Strong Sell Strong Sell Strong Sell Strong Sell Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Bullish doji Star 30 Current
Completed Patterns
Bullish Engulfing 1W 1 Aug 06, 2017
Three Inside Up 1M 2 Jun 17
Deliberation Bearish 1D 2 Aug 14, 2017

Adamis Pharma News & Analysis

Adamis Pharma Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 4.53 4.50 4.55 123,328 -3.54% USD 15:02:47  
  Stuttgart 3.823 3.735 3.994 0 -1.87% EUR 13:30:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Amazon.com 979.18 981.75 973.26 -3.56 -0.36% 1.21M 15:04:07  
  Apple 162.26 162.39 160.93 +0.66 +0.41% 8.56M 15:04:13  
  Alibaba 159.80 160.35 158.70 +2.05 +1.30% 9.48M 15:04:11  
  Tesla 364.43 366.50 362.58 +2.10 +0.58% 1.45M 15:04:13  
  Facebook 170.11 171.37 169.86 -0.89 -0.52% 5.86M 15:04:16  
  Teva ADR 17.80 18.01 17.52 -0.17 -0.95% 9.07M 15:04:20  
  Interpace Diagnostics 1.4290 1.4700 1.1700 +0.3490 +32.31% 23.70M 15:04:16  
  NVIDIA 167.10 168.50 165.32 +0.12 +0.07% 5.70M 15:04:17  
  AMD 12.920 13.190 12.770 -0.100 -0.77% 25.45M 15:04:22  
  Tencent ADR 43.230 43.380 42.960 +2.370 +5.80% 1.69M 14:48:00  

Adamis Pharma Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

14

Equity Type

ORD

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's product portfolio includes specialty pharmaceutical products, such as Epinephrine pre-filled syringe (PFS), APC-5000 dry powder inhaler (DPI), APC-1000 and APC-2000, and biotechnology products, such as TeloB-VAX (vaccine), APC-100, APC-200 and APC-300. The Company's lead product candidate, the Epinephrine Injection USP 1:1000 0.3 milligram Pre-filled Single Dose Syringe, or the Epinephrine PFS, is a pre-filled syringe designed to deliver a premeasured 0.3 milligrams dose of epinephrine for the treatment of anaphylaxis. The Company also has licensed vaccine technology called somatic transgene immunization (STI) technology.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
National Futures Association (United States), National Securities Depository (India), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Board of India (India), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong), Securities Investor Protection Corporation (United States) $10000 Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
U.S. Commodity Futures Trading Commission (United States) Start Trading

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
50%
Bearish
50%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
Write your thoughts about Adamis Pharma
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email